Sanofi Cash Flows From Used In Operating Activities
Sanofi (SNY) reported Cash Flows From Used In Operating Activities of EUR 10.75 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2026-02-17
| Period end | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 6 month as first filed | Cash Flows From Used In Operating Activities 12 month | Cash Flows From Used In Operating Activities 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 10.75B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 3.56B EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 9.08B EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | 1.42B EUR 6-K · filed 2025-10-27 | 1.42B EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | 10.26B EUR 20-F · filed 2026-02-17 | |||
| 2023-06-30 | 3.56B EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 10.53B EUR 20-F · filed 2025-02-13 | |||
| 2022-06-30 | 3.83B EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 10.52B EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 4.73B EUR 6-K · filed 2022-07-28 | 4.75B EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | 7.42B EUR 20-F · filed 2023-02-24 | 7.45B EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | 3.93B EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 7.71B EUR 20-F · filed 2022-02-23 | 7.74B EUR 20-F · filed 2020-03-05 | ||
| 2019-06-30 | 3.18B EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 5.55B EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 7.38B EUR 20-F · filed 2020-03-05 | |||
| 2016-12-31 | 7.84B EUR 20-F · filed 2019-03-08 | |||
| 2015-12-31 | 8.29B EUR 20-F/A · filed 2018-03-16 |